Traf2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TNF Receptor-Associated Factor 2 (TRAF2) is an E3 ubiquitin ligase that serves as a key adaptor protein in TNF receptor signaling. TRAF2 mediates both [NF-κB](/entities/nf-kb) and MAPK activation pathways, playing critical roles in inflammation, cell survival, and stress responses. [@supsup2001]
Traf2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TNF Receptor-Associated Factor 2 (TRAF2) is an E3 ubiquitin ligase that serves as a key adaptor protein in TNF receptor signaling. TRAF2 mediates both [NF-κB](/entities/nf-kb) and MAPK activation pathways, playing critical roles in inflammation, cell survival, and stress responses. [@supsup2001]
Overview
TRAF2 Protein is a protein involved in critical biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, mitochondrial maintenance, or stress response mechanisms that are essential for neuronal health. [@supsup2014]
Dysregulation or mutations in this protein contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders through effects on protein function, inflammatory signaling, mitochondrial function, or cell survival pathways. [@supsup1996]
--- [@supsup2006]
Structure
TRAF2 is a 522 amino acid protein (approximately 56 kDa) with characteristic TRAF domain architecture: [@supsup2018]
RING finger domain (E3 ubiquitin ligase activity)
Zinc fingers (4-7 zinc-finger motifs)
Coiled-coil (leucine zipper) domain
TRAF-C domain (TRAF homology region)
The TRAF-C domain mediates: [@supsup2009]
Homo- and heterotrimerization
Receptor interaction
Downstream effector binding
Molecular Function
TRAF2 functions as both adaptor protein and E3 ubiquitin ligase: [@supsup2017]
[Aβ](/proteins/amyloid-beta)-induced neuronal death
[Neuroinflammation](/mechanisms/neuroinflammation) JNK activation in AD brains
Parkinson's Disease
TRAF2 in dopaminergic neuron survival
Neuroinflammation in PD
TNF-α/TRAFR2 signaling
Contribution to [apoptosis](/entities/apoptosis)
ALS
TRAF2 in motor neuron degeneration
Inflammatory pathways
SOD1 mutations affect signaling
Multiple Sclerosis
Demyelination and inflammation
T cell activation
Cytokine signaling
Stroke/Ischemia
TRAF2 in ischemic injury
TNF-α-mediated damage
Inflammatory response
Therapeutic Implications
TRAF2 as therapeutic target:
TRAF2 E3 ligase inhibitors
Downstream kinase inhibitors
Anti-TNF therapies
JNK inhibitors
Animal Models
TRAF2 knockout mice:
Embryonic lethal (day 10.5-12.5)
Liver degeneration
Reduced NF-κB activation
TNF hypersensitivity
TRAF2 transgenic mice:
Enhanced NF-κB activation
Altered inflammatory responses
Tumor development (with age)
Research Directions
Current research:
TRAF2-selective inhibitors
Structure-based drug design
Ubiquitination modulators
Neuroinflammation therapeutics
Background
The study of Traf2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
<sup>1</sup> Arch RH, Gedrich RW, Thompson CB, Tumor necrosis factor receptor-associated factors (TRAFs): a family of adapter proteins that regulates life and death (1998)
<sup>3</sup> Cheng G, Clemmons VW, Crowell D, et al, The role of TRAF2 in TNF signaling (2014)
<sup>4</sup> Hsu H, Shu HB, Pan MG, Goeddel DV, TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways (1996)
<sup>5</sup> Mattson MP, Meffert MK, Roles for NF-κB in nerve cell survival, plasticity, and disease (2006)
<sup>6</sup> Gao Y, et al, TRAF2 in neurodegeneration (2018)
<sup>7</sup> Wu H, Assembly of post-receptor signaling complexes for TNF receptor family members (2009)
<sup>8</sup> Jiang Y, et al, TRAF2 and neuroinflammation in Alzheimer's disease (2017)